| Symbol | AFGVY |
|---|---|
| Name | AGFA-GAVAERT NV |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 2640 Belgium Septestraat 27 |
| Telephone | +32 3 444 2111 |
| Fax | — |
| — | |
| Website | http://www.agfa.be |
| Incorporation | BE |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Brussels |
| CIK | 0001624776 |
| Description | The Agfa-Gevaert Group develops, produces and distributes an extensive range of analog and digital imaging systems and IT solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. Agfa-Gevaert has three focused business groups: Agfa Graphics, Agfa HealthCare, and Agfa Specialty Products. Agfas headquarters and parent company are located in Mortsel, Belgium. The company has production facilities around the world, with the largest production and research centers in Belgium, the United States, Germany and China. This global production network enables the company to meet the specific needs of each market, to limit the risk of currency fluctuations and to reduce transportation costs. Agfa is commercially active worldwide through more than 40 wholly-owned sales organizations. In countries where Agfa does not have its own sales organization, the market is served by a network of agents, distributors and representatives. Additional info from OTC: |
No news found.